Reliance Chemotex Industries reports a 30% jump in FY26 profit to Rs 5.26 crore, supported by increased spindle capacity and a shift toward specialized technical yarns. Shareholders will receive a final dividend of Rs 0.50 per share, with a record date of September 18, 2026. The company remains focused on value-added product categories to offset stable but modest revenue growth.
Reliance Chemotex Reports FY26 Profit of Rs 5.26 Crore
Profit After Tax (PAT) increased by 30.07% to Rs 5.26 crore, while revenue rose slightly by 1.75% to Rs 356.86 crore.
Reader Takeaway: Growth driven by specialized yarn demand; watch for ongoing tax litigation and raw material price volatility.
What just happened
Reliance Chemotex Industries has announced its financial results for the year ended March 31, 2026, alongside plans for its 48th Annual General Meeting (AGM). The company has recommended a dividend of Rs 0.50 per equity share. The AGM is scheduled for September 24, 2026, with the record date for the dividend set for September 18, 2026.
Why this matters
The company’s move to increase its spindle capacity to 68,256 marks a strategic shift toward value-added, specialized yarns such as flame-retardant materials. Despite a challenging global textile environment, the company managed a 30% profit growth, highlighting improved operational efficiency.
Operational Performance
Revenue remained steady at Rs 356.86 crore, supported by a strong domestic performance of Rs 233.57 crore. The EBITDA margin expanded by 47 basis points to 12.30%, benefiting from cost-optimization efforts and the commissioning of 5.2 MW of captive solar power generation.
Risks to watch
Regulatory exposure remains a key point, with ongoing tax and service tax disputes across various legal forums. Furthermore, a Supreme Court appeal filed by AVVNL regarding a past order remains unresolved. The company also faces inherent sector-specific risks, including volatility in raw material costs and fluctuating energy prices.
Governance
The company reported a minor penalty of Rs 8,260 due to a delay in appointing a compliance officer, which has since been rectified. Statutory auditors have provided an unmodified opinion on the company's financial statements.
What to track next
Investors should monitor the recovery in export markets and the company's ability to maintain high margins as it scales up its specialized product portfolio.